Accelera is uniquely placed to provide mainstream pharma capabilities in response to your preclinical needs.
Accelera offers a complete range of toxicology protocols in multiple test species, including NHPs. From acute to chronic, Study Directors with an average of 20 years industrial experience ensure quality performance, interpretation, review and reporting.
Excellence and Expertise in Oncology R&D, including small molecules, biologics, and CARTs. In vivo tumor models. PK/PD. Pharmacology